Fluvastatin overdosage: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{fluvastatin}} {{CMG}}; {{AE}} {{SS}} ==Overdosage== To date, there has been limited experience with overdosage of fluvastatin. If an overdose occurs, it should be...")
 
(Redirected page to Fluvastatin)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Fluvastatin]]
{{fluvastatin}}
{{CMG}}; {{AE}} {{SS}}
 
==Overdosage==
To date, there has been limited experience with overdosage of fluvastatin. If an overdose occurs, it should be treated symptomatically with laboratory monitoring and supportive measures should be instituted as required.  The dialyzability of fluvastatin sodium and of its metabolites in humans is not known at present [see Warnings and Precautions (5)].
 
In the pediatric population, there have been reports of overdosage with fluvastatin sodium in children including a 2 year-old and the other 3 years of age, either of whom may have possibly ingested fluvastatin sodium. The maximum amount of fluvastatin sodium that could have been ingested was 80 mg (4 x 20 mg capsules). Vomiting was induced by ipecac in both children and no capsules were noted in their emesis. Neither child experienced any adverse symptoms and both recovered from the incident without problems.
 
In the postmarketing experience there have been reports of accidental ingestion of LESCOL tablets in infants up to 3 years of age. In one case, increased serum CPK values were noted. There have been reports of intentional overdose in adolescents with the development of hepatic enzyme elevations, [[convulsions]] and [[gastroenteritis]]/[[vomiting]]/[[diarrhea]]. One case of intentional overdose as suicide attempt in a 15 year-old female reported ingestion of 2,800 mg LESCOL XL with hepatic enzyme elevation.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LESCOL (FLUVASTATIN SODIUM) CAPSULE LESCOL XL (FLUVASTATIN SODIUM) TABLET, EXTENDED RELEASE [NOVARTIS PHARMACEUTICALS CORPORATION] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8a1823e7-26fb-4858-bac7-9e152e5ea16a | publisher =  | date =  | accessdate = 12 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
{{Statins}}
 
[[Category:Statins]]
[[Category:Diols]]
[[Category:Indoles]]
[[Category:Carboxylic acids]]
[[Category:Organofluorides]]
[[Cardiovasular Druf]]
[[Drug]]

Latest revision as of 14:41, 21 July 2014

Redirect to: